Erik Lawrence Kreider - Comment

Document ID: FDA-1978-N-0018-0724
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: September 27 2011, at 12:00 AM Eastern Daylight Time
Date Posted: October 21 2011, at 12:00 AM Eastern Standard Time
Comment Start Date: September 14 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: October 17 2011, at 11:59 PM Eastern Standard Time
Tracking Number: 80f3ccd5
View Document:  View as format xml

View Comment

I urge FDA to investigate not only the sunscreen efficacy of spray sunscreens, but also the safety of such products from the fundamental use perspective and inherent risks associated with application of an aerosolized and volatile formula. I want to emphasize key risks associated with spray formulas: 1. Inhalation hazards of all formula chemicals - what safety data exists for this risk? 2. Vehicle chemistry exposure risks - many spray sunscreens utilize denatured alcohol as the primary vehicle, for example. What is the safety of transdermal exposure to this and other vehicle chemicals not used in cream formulas? 3. Primary user populations - a vast majority of spray sunscreens are used on young children, as parents view this application mode as 'convenient' because it is perceived to eliminate the need to rub the product on their squirmy children's skin. Children are often unable to know much less follow manufacturer's application instructions - how does this impact GRASE status? 4. Testing per OTC monograph - can the manufacturer demonstrate proper formula application density so as to reproduce the SPF testing protocol? FDA has already excluded powder forms; sprays have very similar issues associated with proper and reproducible formula application density.

Related Comments

    View All
Total: 14
Erik Lawrence Kreider - Comment
Public Submission    Posted: 10/21/2011     ID: FDA-1978-N-0018-0724

Oct 17,2011 11:59 PM ET
Erik Lawrence Kreider - Comment
Public Submission    Posted: 10/21/2011     ID: FDA-1978-N-0018-0725

Oct 17,2011 11:59 PM ET
Robin J McGuinness - Comment
Public Submission    Posted: 10/21/2011     ID: FDA-1978-N-0018-0726

Oct 17,2011 11:59 PM ET
Jessica Aloyo, RN - Comment
Public Submission    Posted: 10/21/2011     ID: FDA-1978-N-0018-0728

Oct 17,2011 11:59 PM ET
Richard Frank Somsel - Comment
Public Submission    Posted: 10/21/2011     ID: FDA-1978-N-0018-0729

Oct 17,2011 11:59 PM ET